Beijing Anzhen Hospital, Capital Medical University was founded in April 1984, and Beijing Institute of Heart, Lung& Blood Vessel Diseases was founded in September 1981, both by academician Wu Yingkai, the father of China's thoracic and cardiovascular surgery. Being a joint medical research center, our hospital and institute involve medical, pedagogical, academic activities, preventive care, and international exchanges, functioning as a 3A comprehensive hospital with focus on heart, lung&blood vessel diseases. Beijing Anzhen Hospital is the No. 6 School of Clinical Medicine of Capital Medical University. It was one of the designated hospitals of the 29th Olympic Games.
Under the leadership of the administrative team headed by President Wei Yongxiang and Party Secretary Jin Chunming, Beijing Anzhen Hospital has insisted on the principle of “Outstanding Specialty and Comprehensive Service,” and all the staff members are making a concerted effort to drive on the transformation from a profit-oriented hospital to a research-oriented medical center. With inclusive disciplines and distinctive specialties, the hospital has formed a comprehensive unity of disciplines focusing on cardiovasology. There are 9 clinical centers(cardiology center, cardiac surgery center, pediatric heart center, anesthesia center, cardiac surgery critical care center, emergency critical care center, gerontology center, vascular surgery center, heart transplantation and valvular surgery center), 30 clinical departments, and 11 medical technology departments. Beijing Anzhen Hospital gives full play to the cooperative strength of its key subjects and general subjects, and established chest pain center, maternal fetal consultation center, high-risk pregnant and lying-in woman group consultation center,sleep medical centerand precision medical center. All these efforts have provided excellent services to combined heart disease patients.
Beijing Anzhen Hospital was listed into the first group of the National Clinical Research Center of Cardiovascular Diseases, boasting China's leading cardiovasological studies and Beijing's leading thoracic and cardiovascular surgical studies, as well as China's leading clinical practices in cardiovascular medicine, cardiovascular surgery and geriatrics. It has the Key Laboratory of Remodeling-related Cardiovascular Diseases of MOE, Joint Center for Major Cardiovascular Disease Prevention and Treatment of Beijing City, Key Laboratory of Maternal-fetal Medicine Studies for Fetal Heart Disease, Beijing Engineering Center of Technology and Research on the Medical Apparatus of Cardiac & Cerebral Vessels, Beijing Engineering Research Center for Vascular Prostheses, Beijing International Cooperation Base of Clinical Practices in Cardiovascular Medicine, and Beijing International Cooperation Demonstration Base of Big Medical Data Analysis. As the national base of cultivation of cardiovasological professionals, it has the Training Base for Interventional Diagnosis and Treatment of Cardiovasological Disease of the MOH, Training Base for Interventional Diagnosis and Treatment of Peripheral Vascular of the National Health and Family Planning Commission, Sino-American training Center for Coronary Artery Disease Diagnosis and Treatment, and Sino-French Training Center for Emergency and Disaster Medicine. On February 17, 2014, it was approved to establish the Beijing Institute of Integrated Traditional Chinese and Western Medicine for Cardiovascular and Pulmonary Diseases.
The hospital has laid particular emphases on recruiting and training high-skilled professionals. We have introduced Chen Runsheng---the academician of CAS, Cheng Jing, Zhu Xiaodong, Zhang Yun---the academician of CAE to form a professional team to promote disciplinary development. Currently, professor Sun Lizhong, Ma Changsheng are awarded “Beijing Scholar”. Liu Yinglong, Lv Shuzheng, Ma Changsheng, Sun Lizhong, Wei Yongxiang, Zhou Yujie, Zhao Dong, Meng Xu, Dong Jianzeng and Wen Shaojun are National Secondary Professors. We engaged high-level professionals, including“Changjiang Scholars” and “Haiju Professionals” through our professional strength and sincere faith.
The hospital covers an area of 76,500 m2, and 205,500 m2 of medical care rooms. The fixed assets of the hospital is around 1.7 billion RMB, and the annual income of the hospital is over 4 billion RMB. There are now more than 4,000 employees, including over 600 senior professionals, and more than 900 professionals of medium level. There are 1,500 accommodated beds, including 211 intensive care beds, 31 laminar air flow operating rooms of class 100, class 1,000 and class 10,000, 13 catheterization laboratories ( including MSS ). Our hospital has PET/CT, cyclotron, DSCT，320-row CT and other advanced medical equipments, which provides excellent medical services for patients.
Annually, Beijing Anzhen Hospital has received nearly 2,600,000 patients from both outpatient and emergency departments, and completed nearly 40,000 cases operations, including 10,000 cases cardiac surgeries and 4,300 cases CABG. Besides, over 22,000 cases of coronary angiography are performed, 11,000 cases of PCI and 9,400 cases of surgical procedures are completed each year. In this regard, Beijing Anzhen Hospital topped all the comprehensive hospitals in China. As one of the first medical institutions qualified for organ transplant, the hospital has been carrying out heart transplantation, lung transplantation and combined heart and lung transplantation for many years.
In the new era, the whole staff will continue to make concerted efforts pursuing first-rate quality in teamwork, management and service, in accordance with the spirit of the hospital’s motto “Justice, Diligence, Rigor, Integrity.”